化湿和胃汤联合四联疗法治疗湿热壅滞型胃脘痛临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.1;R573.3+2

基金项目:

国家中医药管理局第七批全国老中医药专家学术经验继承项目(国中医药办人教函〔2022〕76号);开封市科技发展计划项目(2203066)


Clinical Study on Combination Use of Huashi Hewei Decoction and Quadruple Therapy for Epigastric Pain of Damp-Heat Stagnation Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察化湿和胃汤联合四联疗法治疗湿热壅滞型胃脘痛的效果。方法:选取开封市中心医院 2020年5月—2023年6月收治的108例湿热壅滞型胃脘痛患者为研究对象,按随机数字表法分为观察组和对照 组各54例。2组均予常规四联疗法治疗,观察组同期加用化湿和胃汤治疗,2组疗程均为2周。治疗前后评定 中医证候评分、检测胃肠道活动功能指标[胃泌素(GAS)、胃动素(MOT)],比较2组的临床疗效、不良反 应发生率、幽门螺杆菌(Hp) 根除率以及随访6个月期间的复发率。结果:治疗后,观察组总有效率高于对照 组(P<0.05)。2组胃脘疼痛、脘闷灼热、纳呆恶心、口干口苦评分均较治疗前降低(P<0.05),观察组4项 中医证候评分均低于对照组(P<0.05)。2组GAS、MOT水平均较治疗前升高(P<0.05),观察组GAS、MOT 水平均高于对照组(P<0.05)。2组不良反应发生率、Hp根除率、复发率比较,差异均无统计学意义(P> 0.05)。结论:采用化湿和胃汤联合四联疗法治疗湿热壅滞型胃脘痛患者可提高疗效,有效缓解症状,改善胃 肠道活动功能,降低复发风险,安全性好。

    Abstract:

    Abstract: Objective: To observe the curative effect of the combination use of Huashi Hewei Decoction and quadruple therapy on epigastric pain of damp-heat stagnation type. Method:A total of 108 patients with epigastric pain of damp-heat stagnation type admitted to Kaifeng Central Hospital from May 2020 to June 2023 were selected as the study subjects and divided into the observation group and the control group according to the random number table method, with 54 cases in each group. The two groups were treated with conventional quadruple therapy, and the observation group was additionally treated with Huashi Hewei Decoction at the same time. The course of treatment of both groups was two weeks. Before and after treatment, the traditional Chinese medicine syndrome scores were evaluated, the gastrointestinal motility function indexes [gastrin( GAS) and motilin( MOT)] were detected,and the clinical effects, incidence of adverse reactions, eradication rates of helicobacter pylori (Hp) and recurrence rates during 6-month follow-up were compared between the two groups. Results:After treatment,the total effective rate in the observation group was higher than that in the control group (P<0.05). The scores of epigastric pain, epigastric oppression and burning,dementia and nausea,and dry mouth and bitter taste in both groups were reduced when compared with those before treatment (P<0.05), and the above four scores in the observation group were lower than those in the control group (P<0.05). The levels of GAS and MOT in both groups were elevated when compared with those before treatment (P<0.05),and the levels of GAS and MOT in the observation group were higher than those in the control group( P<0.05). There were no significant differences being found in the comparisons of incidence of adverse reactions, Hp eradication rate, and recurrence rate between the two groups (P>0.05). Conclusion: The combination use of Huashi Hewei Decoction and quadruple therapy can improve the curative effect on patients with epigastric pain of dampheat stagnation type,effectively alleviate the symptoms,enhance the gastrointestinal motility function and reduce the risk of recurrence with great safety.

    参考文献
    相似文献
    引证文献
引用本文

娄永亮,张云瑞,潘婷,朱晓恒,刘静宇.化湿和胃汤联合四联疗法治疗湿热壅滞型胃脘痛临床研究[J].新中医,2025,57(10):39-43

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-05-27
  • 出版日期:
文章二维码